Nasenspray (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride, the active ingredient in Nasenspray, is an alpha‑adrenergic agonist presented as a nasal spray for nasal use. It relieves nasal congestion associated with the common cold, sinusitis, and allergic rhinitis in adults and children.

GNH USA supplies Nasenspray as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Xylometazoline Hydrochloride is indicated for nasal decongestion in conditions affecting the upper respiratory tract.

- Common cold: reduces nasal blockage and improves airflow. - Sinusitis: alleviates congestion linked to sinus inflammation. - Allergic rhinitis: relieves nasal obstruction caused by allergic reactions.

Adverse reactions are generally mild and related to local irritation of the nasal mucosa.

Common Side Effects: - Nasal irritation - Burning sensation in the nose - Sneezing - Dryness of nasal mucosa - Headache - Altered taste perception

Serious or Rare Side Effects: - Rebound congestion (rhinitis medicamentosa) - Hypertension - Tachycardia - Severe allergic reaction (anaphylaxis) - Nasal ulceration

Before using Nasenspray, consider the following safety measures.

- Age restriction: not recommended for children under 6 years without medical advice. - Duration of use: limit to 3‑5 days to avoid rebound congestion. - Cardiovascular conditions: use cautiously in patients with hypertension or heart disease. - Pregnancy and lactation: safety not established; consult a healthcare professional. - Drug interactions: avoid concurrent use with monoamine oxidase inhibitors or other nasal decongestants. - Store at room temperature below 25°C: keep in the original container, protect from moisture and direct sunlight.

Xylometazoline Hydrochloride may interact with other sympathomimetic agents.

Major Interactions (Avoid): - MAO inhibitors: may increase hypertensive effects. - Other nasal decongestants (e.g., phenylephrine): risk of excessive vasoconstriction. - Sympathomimetic drugs (e.g., pseudoephedrine): may cause severe hypertension.

Moderate Interactions (Monitor Closely): - Antihypertensive agents: may reduce blood‑pressure control. - Tricyclic antidepressants: potential additive cardiovascular effects. - Beta‑blockers: may blunt tachycardia response.